(Q39270763)

10 September 2017

title

Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen (English)

1 reference

Seyed Hamid Aghaee Bakhtiari

10 September 2017

author

7

0 references

Zahra Sharifzadeh

1

0 references

Fatemeh Rahbarizadeh

2

object named as

Fatemeh Rahbarizadeh

1 reference

10 September 2017

author name string

Mohammad Ali Shokrgozar

3

1 reference

10 September 2017

Davoud Ahmadvand

4

1 reference

10 September 2017

Fereidoun Mahboudi

5

1 reference

10 September 2017

Fatemeh Rahimi Jamnani

6

1 reference

10 September 2017

publication date

1 June 2013

1 reference

10 September 2017

published in

Molecular Biotechnology

1 reference

10 September 2017

volume

54

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

590-601

1 reference

The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Mucins in cancer: function, prognosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Production of murine V-human Cr1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Cell selection and characterization of a novel human endothelial cell specific nanobody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Properties, production, and applications of camelid single-domain antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Nanobody; an old concept and new vehicle for immunotargeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Antibody cocktails: next-generation biopharmaceuticals with improved potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Recombinant polyclonal antibodies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Antibody production: polyclonal-derived biotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Single-domain antibody fragments with high conformational stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Strategies and challenges for the next generation of therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Engineered antibody fragments and the rise of single domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Efficient cancer therapy with a nanobody-based conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Model systems to study the parameters determining the success of phage antibody selections on complex antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Affinity and avidity in antibody-based tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Nanobody-based chimeric receptor gene integration in Jurkat cells mediated by φC31 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

The Production and Characterization of Novel Heavy-Chain Antibodies Against the Tandem Repeat Region of MUC1 Mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12033-012-9601-0

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer

21 January 2018

1 reference

12 December 2020

Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases

1 reference

12 December 2020

Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein

1 reference

12 December 2020

Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49.

1 reference

12 December 2020

Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen

1 reference

12 December 2020

Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma

1 reference

12 December 2020

Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.

1 reference

12 December 2020

Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe

1 reference

12 December 2020

Enzyme immunoassay ELISA and EMIT

1 reference

12 December 2020

Epitope mapping of the human biliary amphipathic, anionic polypeptide: similarity with a calcium-binding protein isolated from gallstones and bile, and immunologic cross-reactivity with apolipoprotein A-I.

1 reference

12 December 2020

In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer

1 reference

12 December 2020

A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations

1 reference

12 December 2020

Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues

1 reference

12 December 2020

Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.

1 reference

12 December 2020

10.1007/S12033-012-9601-0

Identifiers

DOI

1 reference

10 September 2017

1 reference